Alterations of the volatile metabolome in mouse models of Alzheimer's disease

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Kimball, Bruce A ^a   Wilson, Donald A ^b,c   Wesson, Daniel W ^d  

^a NATIONAL WILDLIFE RESEARCH CENTER   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BIOLOGICAL MARKER; FRAGRANCE;

ALZHEIMER DISEASE; ANIMAL; ANIMAL BEHAVIOR; DISEASE MODEL; GENETICS; GENOTYPE; MASS FRAGMENTOGRAPHY; METABOLISM; METABOLOME; METABOLOMICS; MOUSE; PROCEDURES; TRANSGENIC MOUSE; URINE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BEHAVIOR, ANIMAL; BIOMARKERS; DISEASE MODELS, ANIMAL; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GENOTYPE; METABOLOME; METABOLOMICS; MICE; MICE, TRANSGENIC; ODORANTS;

EID: 84954151910     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep19495     Document Type: Article

References (62)

1. Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239-259 (1991).
2. De Leon, M. J. et al. Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobio of Aging 18, 1-11 (1997).
3. Storandt, M., Mintun, M., Head, D. & Morris, J. Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition. Archives of Neuro. 66, 1476-1481 (2009).
4. Knowles, R. B. et al. Plaque-induced neurite abnormalities: Implications for disruption of neural networks in Alzheimer's disease. Proc Natl Academy of Sci USA 96, 5274-5279 (1999).
5. Frank, R. A. et al. Biological markers for therapeutic trials in Alzheimer's disease: Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease. Neurobio of Aging 24, 521-536 (2003).
6. Craig-Schapiro, R., Fagan, A. M. & Holtzman, D. M. Biomarkers of Alzheimer's disease. Neurobio of Dis 35, 128-140 (2009).
7. Jack, C. R. J. et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurology 9, 119-128 (2010).
8. Buckholtz, N. S. Perspective: In search of biomarkers. Nature 475, S8-S8 (2011).
9. Motter, R. et al. Reduction of β-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann. of Neurology 38, 643-648 (1995).
10. Fagan, A. M. et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta;42 in humans. Ann. of Neurology 59, 512-519 (2006).
11. Devanand, D. P. et al. Combining Early Markers Strongly Predicts Conversion from Mild Cognitive Impairment to Alzheimer's Disease. Biol Psychiatry 64, 871-879 (2008).
12. Stambaugh, R. & Weinhouse, S. Urinary enzymes and their diagnostic value in human cancer. Adv Cancer Res 9, 1-45 (1965).
13. Jenkins, R. D., Fenn, J. P. & Matsen, J. M. Review of Urine Microscopy for Bacteriuria. JAMA: The Journal of the American Med Assoc 255, 3397-3403, doi: 10.1001/jama.1986.03370240067039 (1986).
14. Pflumm, M. Animal instinct helps doctors ferret out disease. Nat Med 17, 143-143 (2011).
15. Shirasu, M. & Touhara, K. The scent of disease: volatile organic compounds of the human body related to disease and disorder. J Biochem. 150, 257-266 (2011).
16. Zlatkis, A., Brazell, R. S. & Poole, C. F. The role of organic volatile profiles in clinical diagnosis. Clin Chem 27, 789-797 (1981).
17. McCulloch, M. et al. Diagnostic Accuracy of Canine Scent Detection in Early- and Late-Stage Lung and Breast Cancers. Integrative Cancer Therapies 5, 30-39, doi: 10.1177/1534735405285096 (2006).
18. Willis, C. M. et al. Olfactory detection of human bladder cancer by dogs: proof of principle study. BMJ 329, 712 (2004).
19. Syhre, M., Manning, L., Phuanukoonnon, S., Harino, P. & Chambers, S. T. The scent of Mycobacterium tuberculosis - Part II breath. Tuberculosis 89, 263-266 (2009).
20. Osada, K. et al. The scent of age. Proc R Soc Lond B Biol Sci 270, 929-933 (2003).
21. Mitro, S., Gordon, A. R., Olsson, M. J. & Lundström, J. N. The Smell of Age: Perception and Discrimination of Body Odors of Different Ages. PLoS ONE 7, e38110 (2012).
22. Pratico, D., Lee, M. Y. V., Trojanowski, J. Q., Rokach, J. & Fitzgerald, G. A. Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo. FASEB J 12, 1777-1783 (1998).
23. Pratico, D. Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows. Annals of the NY Academy of Sci. 1147, 70-78 (2008).
24. Kavaliers, M., Choleris, E. & Pfaff, D. W. Recognition and avoidance of the odors of parasitized conspecifics and predators: Differential genomic correlates. Neurosci & Biobehav Revs. 29, 1347-1359 (2005).
25. Penn, D. & Potts, W. K. Chemical signals and parasite-mediated sexual selection. Trends in Ecology & Evolution 13, 391-396, doi: http://dx.doi.org/10.1016/S0169-5347(98)01473-6 (1998).
26. Hsiao, K. et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102 (1996).
27. Chishti, M. A. et al. Early-onset Amyloid Deposition and Cognitive Deficits in Transgenic Mice Expressing a Double Mutant Form of Amyloid Precursor Protein 695. J. Biol. Chem. 276, 21562-21570, doi: 10.1074/jbc.M100710200 (2001).
28. Pype, S., Moechars, D., Dillen, L. & Mercken, M. Characterization of amyloid β peptides from brain extracts of transgenic mice overexpressing the London mutant of human amyloid precursor protein. J neurochem. 84, 602-609, doi: 10.1046/j.1471-4159.2003.01556.x (2003).
29. Wesson, D. W., Keller, M., Douhard, Q., Baum, M. J. & Bakker, J. Enhanced urinary odor discrimination in female aromatase knockout (ArKO) mice. Horm Behav 49, 580-586 (2006).
30. Wesson, D. W., Levy, E., Nixon, R. A. & Wilson, D. A. Olfactory Dysfunction Correlates with β-Amyloid Plaque Burden in an Alzheimer's Disease Mouse Model. J Neurosci 30, 505-514 (2010).
31. Rankin, C. H. et al. Habituation revisited: An updated and revised description of the behavioral characteristics of habituation. Neurobio. of Learning and Memory 92, 135-138 (2009).
32. Wilson, D. A. & Linster, C. Neurobiology of a Simple Memory. J Neurophysiol 100, 2-7, doi: 10.1152/jn.90479.2008 (2008).
33. Lommen, A. MetAlign: Interface-Driven, Versatile Metabolomics Tool for Hyphenated Full-Scan Mass Spectrometry Data Preprocessing. Analytical Chemistry 81, 3079-3086, doi: 10.1021/ac900036d (2009).
34. Tikunov, Y. M., Laptenok, S., Hall, R. D., Bovy, A. & de Vos, R. C. MSClust: a tool for unsupervised mass spectra extraction of chromatography-mass spectrometry ion-wise aligned data. Metabolomics 8, 714-718 (2013).
35. Benjamini, Y. & Hochberg, Y. Controlling the False Discovery Rate - A Practical and Powerful Approach to Multiple Testing. J Roy Stat Soc B - Methodol 57, 289-300 (1995).
36. Kawarabayashi, T. et al. Age-Dependent Changes in Brain, CSF, and Plasma Amyloid {beta} Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease. J. Neurosci. 21, 372-381 (2001).
37. Westerman, M. A. et al. The Relationship between Abeta and Memory in the Tg2576 Mouse Model of Alzheimer's Disease. J. Neurosci. 22, 1858-1867 (2002).
38. Harvey, S., Jemilio, B. & Novotny, M. V. Pattern of volatile compounds in dominant and subordinate male mouse urine. J Chemical Ecology 15, 2061-2072 (1989).
39. Zala, S. M. et al. Genetic resistance to infection influences a male's sexual attractiveness and modulation of testosterone. Brain, Behav, and Immunity 22, 381-387, doi: http://dx.doi.org/10.1016/j.bbi.2007.09.003 (2008).
40. Johnston, R. E. & Bullock, T. A. Individual recognition by use of odours in golden hampsters: the nature of individual representations. Animal Behaviour 61 (2001).
41. Singh, P. B., Brown, R. E. & Roser, B. MHC antigens in urine as olfactory recognition cues. Nature 327, 161-164 (1987).
42. Bodyak, N. & Slotnick, B. Performance of mice in an automated olfactometer: odor detection, discrimination and odor memory. Chem Senses 24, 637-645 (1999).
43. Chapuis, J. & Wilson, D. A. Bidirectional plasticity of cortical pattern recognition and behavioral sensory acuity. Nat Neurosci 15, 155-161 (2011).
44. Barnes, D. C., Hofacer, R. D., Zaman, A. R., Rennaker, R. L. & Wilson, D. A. Olfactory perceptual stability and discrimination. Nat Neurosci 11, 1378-1380 (2008).
45. Brown, R. E. Mammalian social odors. Adv Study Behav 10, 107-161 (1979).
46. Doty, R. L. Odor-guided behavior in mammals. Experentia 42, 257-271 (1986).
47. Baum, M. J. & Keverne, E. B. Sex difference in attraction thresholds for volatile odors from male and estrous female mouse urine. Hormones and Behavior 41, 213-219 (2002).
48. Rijk, J. C. W. et al. Metabolomics Approach to Anabolic Steroid Urine Profiling of Bovines Treated with Prohormones. Analytical Chemistry 81, 6879-6888, doi: 10.1021/ac900874m (2009).
49. de Bok, F. A. M. et al. Volatile Compound Fingerprinting of Mixed-Culture Fermentations. Applied and Env Microbio 77, 6233-6239, doi: 10.1128/aem.00352-11 (2011).
50. Coble, J. B. & Fraga, C. G. Comparative evaluation of preprocessing freeware on chromatography/mass spectrometry data for signature discovery. J Chromatography A 1358, 155-164, doi: http://dx.doi.org/10.1016/j.chroma.2014.06.100 (2014).
51. Niu, W., Knight, E., Xia, Q. & McGarvey, B. D. Comparative evaluation of eight software programs for alignment of gas chromatography-mass spectrometry chromatograms in metabolomics experiments. J Chromatography A 1374, 199-206, doi: http://dx.doi.org/10.1016/j.chroma.2014.11.005 (2014).
52. Demetrius, L. Of mice and men. Vol. 6 (2005).
53. Schaefer, M. L. et al. Mouse Urinary Biomarkers Provide Signatures of Maturation, Diet, Stress Level, and Diurnal Rhythm. Chem Senses 35, 459-471, doi: 10.1093/chemse/bjq032 (2010).
54. Matsumura, K. et al. Urinary Volatile Compounds as Biomarkers for Lung Cancer: A Proof of Principle Study Using Odor Signatures in Mouse Models of Lung Cancer. PLoS ONE 5, e8819, doi: 10.1371/journal.pone.0008819 (2010).
55. Kwak, J. et al. Genetically-Based Olfactory Signatures Persist Despite Dietary Variation. PLoS ONE 3, e3591, doi: 10.1371/journal.pone.0003591 (2008).
56. Miyashita, K. & Robinson, A. B. Identification of compounds in mouse urine vapor by gas chromatography and mass spectrometry. Mechanisms of Ageing and Dev. 13, 177-184 (1980).
57. Röck, F., Mueller, S., Weimar, U., Rammensee, H.-G. & Overath, P. Comparative Analysis of Volatile Constituents from Mice and their Urine. J Chemical Ecology 32, 1333-1346, doi: 10.1007/s10886-006-9091-2 (2006).
58. Schwende, F. J., Wiesler, D., Jorgenson, J. W., VCarmack, M. & Novotny, M. Urinary Volatile Constituents of the House Mouse, Mus- Musculus, and Their Endocrine Dependency. J Chemical Ecology 12, 277-296 (1986).
59. Klegeris, A., Schulzer, M., Harper, D. & McGeer, P. Increase in core body temperature of Alzheimer's disease patients as a possible indicator of chronic neuroinflammation: a meta-analysis. Gerontology 53, 7-11 (2007).
60. Garner, C. E. et al. Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. The FASEB Journal 21, 1675-1688, doi: 10.1096/fj.06-6927com (2007).
61. Xue, R. et al. Investigation of volatile biomarkers in liver cancer blood using solid-phase microextraction and gas chromatography/mass spectrometry. Rapid Communications in Mass Spectrometry 22, 1181-1186, doi: 10.1002/rcm.3466 (2008).
62. Timm, D. E., Baker, L. J., Mueller, H., Zidek, L. & Novotny, M. V. Structural basis of pheromone binding to mouse major urinary protein (MUP-I). Protein Sci 10, 997-1004, doi: 10.1110/ps.52201 (2001).